While Novavax has said that it has the capacity to manufacture two billion doses of its vaccine per year, the need for another vaccine alternative looks to be muted at best.
Although the bears are in control, the stalling negative momentum indicates a turnaround is possible.
Your browser doesnt support iframes.
Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper.
Data may be intentionally delayed pursuant to supplier requirements.
Short term oscillators have turned positive.